Seattle Genetics Inc (SGEN) Posts Mixed Q2 Results
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
NSLR, OCTV, ACB, More
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
Seattle Genetics Inc (NASDAQ: SGEN) reported Q2 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $10.97 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Lightwave Logic, Inc. (LWLG) Reports Q2 Loss of $0.04
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
